paediatrics Brussels 17

Epidemiology

• While HL represents only approximately 4–5% of all cancers in children < 15 y. • 16% in the adolescent, making HL the most

common malignancy within this age group (15–19 years old)

Bleyer, W.A., O ’ Leary, M., Barr, R. & Ries, L.A.G. (eds) (2006) National Cancer Institute, NIH Pub. No. 06-5767 Bethesda, MD